A pilot study of 0.4% povidone-iodine nasal spray to eradicate SARS-CoV-2 in the nasopharynx
Sirijatuphat et al., medRxiv, doi:10.1101/2022.08.18.22278340
https://c19early.org/sirijatuphat3.html